NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 31, 2026
$3.94
· of 52w range
· above low
· to high
$0.2552w low
$7.5052w high
Market Cap
$128M
P/E
-8.9
EPS
$-0.44
your badges
52W Range
$0–$8
Analyst Rating
BUY
Price Target
$133
P/E
-8.9
ROE
-2175.0%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
NRSN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.94
Market Cap
$128M
P/E
-8.9
EPS
$-0.44
ROE
-2175.0%
52W Range
$0–$8
NRSN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-0.442020-12-31 → 2025-12-31
Free Cash Flow$-8M2021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | NRSN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -8.95Y avg ≈-2.0 | ≈-2.0 | · | · | |
| P/B | -82.1 | · | · | · | |
| Price / FCF | -16.7 | · | · | · | |
| Price / Cash Flow | -16.7 | · | · | · | |
| Price / Tangible Book | 55.2 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | NRSN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -397.1%5Y avg ≈-212.5% | ≈-212.5% | -69.0% | Weak | |
| ROE | -2175.0%5Y avg ≈-1091.0% | ≈-1091.0% | 28.3% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | NRSN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 0.35Y avg ≈5.4 | ≈5.4 | 3.2 | Low liquidity | |
| Quick Ratio | 0.15Y avg ≈4.6 | ≈4.6 | 1.9 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
24.5%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 27, 2026 | $-2.10 | $-3.26 | 35.7% |
| June 30, 2025 | $-0.19 | $-0.20 | 6.9% | |
| Dec. 31, 2024 | $-0.06 | $-0.12 | 48.8% | |
| Sept. 30, 2024 | $-0.11 | $-0.16 | 32.6% | |
| June 30, 2024 | $-0.02 | $-0.20 | 90.2% | |
| March 31, 2024 | $-0.35 | $-0.21 | -67.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $6M | $6M | $7M | $6M | · | · | |
| SG&A Expense | $5M | $4M | $5M | $5M | $3M | $393.0K | |
| Operating Expenses | · | · | · | $77.0K | $19.0K | · | |
| Operating Income | $-11M | $-10M | $-12M | $-11M | $-6M | $-3M | |
| Interest Expense | · | · | $2M | $45.0K | $1M | $1.0K | |
| Interest Income | · | · | $4M | $1M | $3M | $61.0K | |
| Other Non-op | $-40.0K | $-308.0K | $2M | $62.0K | · | · | |
| Net Income | $-11M | $-10M | $-10M | $-10M | $-4M | $-3M | |
| EPS (Basic) | $-0.44 | $-0.54 | $-0.74 | $-0.91 | $-0.65 | $-0.51 | |
| EPS (Diluted) | $-0.44 | $-0.54 | $-0.74 | $-0.91 | $-0.65 | $-0.51 | |
| Shares (Basic) | 25,481,343 | 18,602,082 | 13,640,168 | 11,504,521 | · | · | |
| Shares (Diluted) | 25,481,343 | 18,602,082 | 13,640,168 | 11,504,521 | · | · | |
| EBITDA | $-11M | $-10M | $-13M | $-14M | $-6M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $166.0K | $3M | $3M | $4M | $11M | $699.0K | |
| Prepaid Expense | $80.0K | $87.0K | $70.0K | · | · | · | |
| Current Assets | $778.0K | $4M | $3M | $7M | $11M | $766.0K | |
| PP&E (Net) | $58.0K | $66.0K | $85.0K | $77.0K | $19.0K | $13.0K | |
| PP&E (Gross) | $134.0K | $126.0K | $123.0K | $94.0K | · | · | |
| Accum. Depreciation | $76.0K | $60.0K | $38.0K | $17.0K | · | · | |
| Total Assets | $1M | $5M | $3M | $8M | $11M | $779.0K | |
| Accounts Payable | · | · | $1M | $475.0K | $65.0K | $13.0K | |
| Current Liabilities | $3M | $2M | $3M | $2M | $597.0K | $120.0K | |
| Capital Leases | $72.0K | · | $73.0K | · | · | · | |
| Total Liabilities | $3M | $2M | $5M | $2M | $2M | $120.0K | |
| Retained Earnings | $-48M | $-37M | $-26M | $-21M | $-8M | $-4M | |
| Stockholders' Equity | $-2M | $3M | $-2M | $6M | $11M | $659.0K | |
| Liabilities + Equity | $1M | $5M | $3M | · | · | · | |
| Shares Outstanding | 32,557,174 | 23,228,941 | 15,379,042 | 11,781,963 | 10,943,534 | · |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $557.0K | $2M | $2M | · | · | |
| Operating Cash Flow | $-8M | $-10M | $-8M | $-8M | $-2M | $-695.0K | |
| CapEx | $8.0K | $3.0K | $29.0K | $70.0K | $17.0K | $9.0K | |
| Investing Cash Flow | $-8.0K | $1.0K | $3M | $-4M | $-17.0K | $-9.0K | |
| Stock Issued | $7.0K | · | · | · | · | · | |
| Net Stock Activity | $7.0K | · | · | · | · | · | |
| Financing Cash Flow | $4M | $11M | $4M | $4M | $12M | $508.0K | |
| Free Cash Flow | $-8M | $-10M | $-8M | $-8M | $-2M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -397.1% | -263.1% | -207.2% | -128.9% | -66.2% | · | |
| ROE | -2175.0% | -2478.2% | -568.3% | -150.0% | -83.6% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.3 | 2.2 | 0.8 | 4.3 | 19.1 | · | |
| Quick Ratio | 0.1 | 1.7 | 0.8 | 2.1 | 18.5 | · | |
| Interest Coverage | · | · | -6.0 | -301.2 | -4.7 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.05 | $0.11 | · | · | · | · | |
| Cash Flow / Share | $-0.30 | $-0.54 | · | · | · | · | |
| Cash / Share | $0.01 | $0.15 | · | · | · | · | |
| EPS (TTM) | $-0.44 | $-0.54 | $-0.74 | $-0.91 | $-0.65 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-11M | $-10M | $-10M | $-10M | $-4M | · | |
| Market Cap | $25M | $28M | · | · | · | · | |
| P/E | -1.7 | -2.2 | -1.1 | -1.3 | -3.8 | · | |
| P/B | -16.0 | 10.8 | · | · | · | · | |
| P / Tangible Book | · | 10.8 | · | · | · | · | |
| P / Cash Flow | -3.3 | -2.8 | · | · | · | · | |
| P / FCF | -3.3 | -2.7 | · | · | · | · | |
| Earnings Yield | -57.2% | -45.0% | -94.3% | -74.6% | -26.4% | · |
No quarterly filings for NRSN
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-11M | $-10M | $-10M | $-10M | $-4M |
| Diluted EPS | $-0.44 | $-0.54 | $-0.74 | $-0.91 | $-0.65 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 0.3 | 2.2 | 0.8 | 4.3 | 19.1 |
| Quick Ratio | 0.1 | 1.7 | 0.8 | 2.1 | 18.5 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-8M | $-10M | $-8M | $-8M | $-2M |
Institutional owners (13F) 12 filers · $279K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
12
Value held
$279K
New positions
2
Exited positions
3
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 2 (-1 vs prior Q) | 3 (+1 vs prior Q) | 2 (+1 vs prior Q) | 2 (-1 vs prior Q) | +18K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| UBS Group AG | $78,218 | 108,636 | 28.06% | Shares |
| Independent Advisor Alliance | $72,000 | 100,000 | 25.83% | Shares |
| Yorkville Advisors Global, LP | $56,160 | 78,000 | 20.15% | Shares |
| COMMONWEALTH EQUITY SERVICES, LLC | $16,400 | 22,775 | 5.88% | Shares |
| PNC Financial Services Group, Inc. | $15,228 | 21,150 | 5.46% | Shares |
| Pathstone Holdings, LLC | $11,900 | 16,528 | 4.27% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $11,426 | 15,870 | 4.10% | Shares |
| XTX Topco Ltd | $8,261 | 11,473 | 2.96% | Shares |
| Creative Planning | $8,215 | 11,410 | 2.95% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $757 | 1,000 | 0.27% | Shares |
| SBI Securities Co., Ltd. | $184 | 255 | 0.07% | Shares |
| HRT FINANCIAL LP | $7 | 10,515 | 0.00% | Shares |
Company insiders 3 insiders · 3 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Or Eisenberg | Chief Financial Officer | March 26, 2026 A | 1,254,050 | 0 | 0 | $0 |
| Niva Russek-Blum | Chief Technology Officer | March 26, 2026 A | 467,953 | 0 | 0 | $0 |
| Hagit Binder | General Manager | March 26, 2026 A | 521,806 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
NRSN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 9 analysts
BUY
Median target
$160.00
+3966.1%
2 22.2%
Strong Buy
6 66.7%
Buy
1 11.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
3 analysts · 2026-09-20Mean target $133.33 +3288.4%
← Below all targets
Current price $3.94
Low$60.00
Mean$133.33
High$180.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NRSN | $25M | -1.7 | · | · | -2175.0% | · |
| PLUR | $23M | -0.9 | -23.9% | -2344.6% | 159.5% | 44.6% |
| QNRX | $757M | · | · | · | -201.7% | · |
| CMMB | · | 91.7 | · | · | -69.5% | · |
| ENLV | $167M | 0.0 | · | · | 126.2% | · |
| EVGN | · | 1.0 | · | -220.2% | 1107.0% | -6.2% |
| CLGN | $18M | -1.5 | · | -484.6% | -117.6% | 64.8% |
| URGN | $1.13B | · | 21.4% | -139.8% | 154.4% | 88.7% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 31, 2026